Orphan Drugs and Rare Diseases Global Congress 2020 Europe

This conference brings together stakeholders in the orphan drugs industry to discuss and network with top tier government, pharmaceuticals, biotechs, non-profit organisations, orphan drug developers, research organisations as well as patients groups and advocates.

Dr Jonathan Appleby, Chief Scientific Officer

Panel - Cell and Gene Therapies for Rare Diseases

09.50-10.30, Tuesday 17th March

 

Find out more here

  • RT : I am delighted to announce new Life Science Opportunity Zones which will boost this important thriving sector. The… https://t.co/4aKZVaZqgE 1 day 9 hours ago

Discover who we are